StockData
Immuron Ltd logo

Immuron Ltd (IMRN) stock

IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 24, 2026Score 4/30
$0.87−0.03 (-3.20%)

Close on Nov 17, 2026Market cap $7.03MP/E –Yield –

Immuron cash

Cash and short-term investments held at the end of each period.

Immuron's cash was A$9.02M at Jun 30, 2026. For fiscal 2026 it was A$9.02M, up 218.6% from the year before. Over ten years it grew 14.7% a year on average. The highest annual figure on record is A$25.05M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2026Jun 30, 2026A$9.02M+218.6%
FY2025Jun 30, 2025A$2.83M-75.7%
FY2024Jun 30, 2024A$11.66M-32.1%
FY2023Jun 30, 2023A$17.16M-22.4%
FY2022Jun 30, 2022A$22.11M-11.7%
FY2021Jun 30, 2021A$25.05M+670.6%
FY2020Jun 30, 2020A$3.25M-36.5%
FY2019Jun 30, 2019A$5.12M+8.3%
FY2018Jun 30, 2018A$4.73M+18.3%
FY2017Jun 30, 2017A$3.99M+74.4%
FY2016Jun 30, 2016A$2.29M-26.5%
FY2015Jun 30, 2015A$3.12M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026A$9.02M-59.2%
Q4 FY2025CQ2 2025Jun 30, 2025A$2.83M-88.7%
Q4 FY2024CQ2 2024Jun 30, 2024A$11.66M+258.6%
Q4 FY2023CQ2 2023Jun 30, 2023A$17.16M+235.2%
Q4 FY2022CQ2 2022Jun 30, 2022A$22.11M+367.7%
Q4 FY2021CQ2 2021Jun 30, 2021A$25.05M+527.0%
Q4 FY2020CQ2 2020Jun 30, 2020A$3.25M+41.9%
Q4 FY2019CQ2 2019Jun 30, 2019A$5.12M+64.3%
Q4 FY2018CQ2 2018Jun 30, 2018A$4.73M–
Q4 FY2017CQ2 2017Jun 30, 2017A$3.99M–
Q4 FY2016CQ2 2016Jun 30, 2016A$2.29M–
Q4 FY2015CQ2 2015Jun 30, 2015A$3.12M–

More Immuron figures

See a number that looks wrong?